Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
polyarticular juvenile rheumatoid arthritis; lectin deficiency Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Mannose-binding lectin deficiency is associated with early onset of polyarticular juvenile rheumatoid arthritis: A cohort study
Arthritis Research & Therapy, 04/18/08
Print     Email This Article     Save in My Library   Free Abstract
Dolman KM et al. - Deficiency of mannose-binding lectin (MBL), an innate immune protein does not increase susceptibility to juvenile rheumatoid arthritis (JRA) but is associated with a younger age of onset of juvenile polyarthritis.

Methods
  • Aim was to determine whether 1. MBL deficiency is associated with susceptibility to JRA and 2. MBL2 genotypes are associated with JRA severity
  • In a retrospective study including 218 pts with polyarthritis (n=67) and oligoarthritis (n=151), clinical and laboratory disease variables were obtained
  • Healthy Caucasian adults (n=194) served as controls
  • MBL2 gene mutations were determined by Taqman analysis
  • Functional MBL plasma concs. were measured by ELISA
  • Associations between clinical and laboratory variables and MBL2 genotypes were determined by Kruskal-Wallis and Chi-square tests

Results
  • MBL2 genotype frequencies were similar in polyarthritis and oligoarthritis pts
  • MBL plasma concs. were associated with the high, medium and low MBL genotype expression groups
  • In polyarthritis pts, the low-expressing MBL2 genotypes were associated with early age of onset of disease
  • In oligoarthritis pts, low-expressing MBL2 genotypes were more often in remission (81%) vs. medium (54%) and high (56%) genotype
  • Arthritis severity index, presence of radiographic erosions and antinuclear antibody positivity, were not associated with MBL2 genotypes

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.